| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CHIASMA INC | 2,080,595 | 40,696,000 | 24.56% | ||
| 2 | Proteon Therapeutics | 2,017,872 | 31,277,000 | 18.88% | ||
| 3 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 24,688,000 | 14.90% | ||
| 4 | SIENTRA INC | 2,199,012 | 13,018,000 | 7.86% | ||
| 5 | CEMPRA INC | 383,935 | 11,948,000 | 7.21% | ||
| 6 | Dicerna Pharmaceuticals | 945,757 | 11,226,000 | 6.77% | ||
| 7 | TOBIRA THERAPEUTICS INC | 589,244 | 5,898,000 | 3.56% | ||
| 8 | LOMBARD MEDICAL INC | 3,473,452 | 4,446,000 | 2.68% | ||
| 9 | Innocoll | 555,555 | 4,178,000 | 2.52% | ||
| 10 | CELLECTIS S A | 100,000 | 3,100,000 | 1.87% | ||
| 11 | ADAPTIMMUNE THERAPEUTICS PLC | 250,000 | 3,013,000 | 1.82% | ||
| 12 | REGULUS THERAPEUTICS INC | 327,350 | 2,851,000 | 1.72% | ||
| 13 | CymaBay Therapeutics | 1,600,000 | 2,672,000 | 1.61% | ||
| 14 | DERMIRA INC | 70,000 | 2,419,000 | 1.46% | ||
| 15 | ANTHERA PHARMACEUTICALS I | 437,994 | 2,032,000 | 1.23% | ||
| 16 | CHEMOCENTRYX INC | 215,000 | 1,739,000 | 1.05% | ||
| 17 | OncoGenex Pharmaceuticals Inc | 396,104 | 475,000 | 0.29% | ||
| 18 | EPIRUS BIOPHARMA | 7,896 | 24,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-014690, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
